Boston Bio Systems Ltd
BSE: 531458
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 0.06-75.9% | 0.24+35.6% | 0.18-6.2% | 0.19 |
| Other Income | — | 0.00 | 0.00 | 0.00 |
| Total Income | 0.06-75.9% | 0.24+35.6% | 0.18-6.2% | 0.19 |
| EXPENSES | ||||
| Expenditure | 0.07-62.0% | 0.19+51.4% | 0.13-81.4% | 0.68 |
| Tax | 0.00-100.0% | 0.01-2.2% | 0.01 | 0.00 |
| PROFIT | ||||
| PBT | -0.01-126.6% | 0.05-1.9% | 0.05+110.9% | -0.49 |
| Net Profit | -0.01-135.5% | 0.04-1.7% | 0.04+108.2% | -0.49 |
| KEY METRICS | ||||
| OPM % | — | 21.50%-8.20pp | 29.70%+129.70pp | -100.00% |
| NPM % | -23.73%-39.83pp | 16.10%-6.12pp | 22.22%+122.22pp | -100.00% |
| EPS | -0.02-133.3% | 0.06+0.0% | 0.06-91.4% | 0.70 |
Corporate Events
Board Meeting
The Board of Directors will consider and approve the Unaudit…
BSE Filing ↗Board Meeting
The Annual General Meeting ("AGM") of the Members of Boston …
BSE Filing ↗Board Meeting
The Board of Directors considered and approved the Audited F…
BSE Filing ↗Board Meeting
A meeting of the Board of Directors of Boston Commerce Limit…
BSE Filing ↗Board Meeting
The Extra-ordinary General Meeting of the Company will be he…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the r…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗Board Meeting
Closure of trading window for the quarter ending 30th Septem…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Financial Results of the Comp…
BSE Filing ↗Board Meeting
Consider and approve unaudited Financial Results of the Comp…
BSE Filing ↗Board Meeting
Intimation Of Board Meeting, Consider and approve unaudited …
BSE Filing ↗Board Meeting
consider and approve the Standalone Unaudited Financial Resu…
BSE Filing ↗